Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
ASND Ascendis Pharma A/S
- 144.080
- +1.590+1.12%
Close Feb 14 16:00 ET
- 144.080
- 0.0000.00%
Post 17:04 ET
8.62BMarket Cap-21.03P/E (TTM)
146.905High141.822Low551.28KVolume142.850Open142.490Pre Close79.42MTurnover0.93%Turnover RatioLossP/E (Static)59.84MShares161.00052wk High-77.75P/B8.56BFloat Cap111.09052wk Low--Dividend TTM59.40MShs Float183.980Historical High--Div YieldTTM3.57%Amplitude11.920Historical Low144.055Avg Price1Lot Size
About Ascendis Pharma A/S Company
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.
Company Profile
SymbolASND
Company NameAscendis Pharma A/S
Listing DateJan 28, 2015
Issue Price18.00
Founded2006
CEOMr. Jan Moller Mikkelsen
MarketNASDAQ
Employees1017
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressTuborg Boulevard 12
CityHellerup
ProvinceCapital Region
CountryDenmark
Zip Code2900
Phone45-70-22-22-44
Company Executives
- Name
- Position
- Salary
- Jan Moller Mikkelsen
- President, Chief Executive Officer and Director
- --
- Scott T Smith
- Executive Vice President and Chief Financial Officer
- --
- Lotte Sonderbjerg
- Executive Vice President and Chief Administrative Officer
- --
- Aimee Shu
- Executive Vice President and Chief Medical Officer
- --
- Michael Wolff Jensen
- Executive Vice President and Chief Legal Officer
- --
- Mads Bodenhoff
- Senior Vice President, Head of Finance and Principal Accounting Officer
- --
- Dr. Stina Singel, M.D.
- Executive Vice President and Head of Clinical Development, Oncology
- --
- Flemming Steen Jensen
- Executive Vice President, Product Supply and Quality
- --
- Dr. Kennett Sprogoe, PhD
- Executive Vice President and Head of Innovation and Research
- --
- Jay Donovan Wu
- Executive Vice President and U.S. President
- --
- Dr. Albert Cha, M.D.,PhD
- Chairman of the Board
- --
- Lisa Bright
- Independent Director
- --
- Siham Imani
- Independent Director
- --
- William Carl Fairey
- Independent Director
- --
- Lars Holtug
- Independent Director
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.